Extracorporeal Membrane Oxygenation Machine Market Research Report: Information by Component (Pumps, Oxygenators, Cannula and others), Modality, Application and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027
Extracorporeal membrane oxygenation machine market has been registering increasing revenue as a result of several factors that include increasing use of ECMO machine for open heart surgeries or procedures that involve life threatening cardiovascular and respiratory diseases. Expanding geriatric population, rising prevalence of lung diseases, improvement in ECMO technology are expected to be other driving forces for the ECMO machine market over 2019-2025. Increasing number of hospitals and other medical facilities have been reported to have ECMO machines. For instance, in a 2017 report published by the World Health Organization, around 306 hospitals in the U.S. used ECMO machines for the treatment of lung and heart diseases. Additionally, there were 9385 instances of ECMO administration in U.S. hospitals in 2017.
Extracorporeal membrane oxygenation machine market is anticipated to record a CAGR of 4.8% over 2019-2025 and amass an estimated revenue of USD 267.60 million by 2025.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8119
ECMO machines are also known as life support machines. They are designed to oxygenate blood outside the patient’s body and allows the heart and lungs to rest. The ECMO machine works by taking the blood out of the body, into an artificial lung where it adds oxygen and removes carbon dioxide. The blood is then armed to body temperature and pumped back into the body.
Some of the factors such as chances of bleeding, stroke, infection and kidney failure may hamper the growth of ECMO machine market. However, in spite of risks, ECMO machines have been known to save lives and are an integral part of heart and lung bypass surgeries which will continue to add to ECMO machine market revenue by 2025.
Segmentation:
ECMO machine market divides the market on the basis of component, modality, application and region.
ECMO machine consists of different components such as pumps, controllers, oxygenators, cannula and accessories. ECMO machine market has registered revenue growth on as each component segment has showed growth prospects as ECMO machines have come to be more widely used. Oxygenators segment is expected to record considerable CAGR over 2019-2025 and hold a major ECMO machine market share due to increased application ECMO machines in treatment of heart and lung diseases.
On the basis of modality, ECMO machine market is further segmented as veno-arterial, arteries-venous and veno-venous. Due to the expansive use of veno-arterial ECMO machines in case of cardiac collapse, veno-arterial modal segment of ECMO machine market is expected to hold a major market share while increasing cases of cardiac shock is expected to help in the fast growth of veno-venous modal segment in the coming years.
ECMO machine market has several application segmentations which include respiratory, cardiac and extracorporeal cardiopulmonary resuscitation. Due to the crucial role that ECMO machines play in case of pulmonary function support, respiratory application is anticipated to witness substantial growth in the coming years. On the other hand, increasing incidence of cardiac illnesses is expected to fuel the growth of extracorporeal cardiopulmonary resuscitation or ECPR segment.
On the basis of region ECMO machine market is subdivided into Americas, Europe, Asia Pacific and MEA.
Owing to the lifesaving qualities of ECMO machines, they are being increasingly incorporated into hospitals and other medical institutions which has urged ECMO machine market players to invest more into R&D that support the technological growth of ECMO machines. As a result, ECMO machine market has become a competitive space where some of the giants of healthcare device manufacturers are vying with each other to capture a greater market share. Some of these companies include, Medtronic, Siemens, Abbott, Getinge Group, Agilent technologies, Livanova PLC, Terumo Corporation, Nipro Corporation, Fresenius Medical Care AG & Co, ALung technologies etc.
To cite an instance of the growing interest that the ECMO machine market is witnessing it can be mentioned that ALung Technologies, a compny that is considered to be one of the leaders in the low-flow extracorporeal carbon dioxide removal technology, closed a $36 million Series C funding round in 2017. According to plans reported by ALung Technologies, the fund was meant to support the trial for FDA approval of the Hemolung Respiratory Assist System (RAS) developed by the company that was essentially a minimally invasive artificial lung device designed to remove carbon dioxide independently of the lungs through a process called Respiratory Dialysis.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/extracorporeal-membrane-oxygenation-machine-market-8119
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: [email protected]
Extracorporeal membrane oxygenation machine market has been registering increasing revenue as a result of several factors that include increasing use of ECMO machine for open heart surgeries or procedures that involve life threatening cardiovascular and respiratory diseases.
Increasing number of hospitals and other medical facilities have been reported to have ECMO machines.
They are designed to oxygenate blood outside the patient’s body and allows the heart and lungs to rest.
Some of the factors such as chances of bleeding, stroke, infection and kidney failure may hamper the growth of ECMO machine market.
However, in spite of risks, ECMO machines have been known to save lives and are an integral part of heart and lung bypass surgeries which will continue to add to ECMO machine market revenue by 2025.Segmentation:ECMO machine market divides the market on the basis of component, modality, application and region.ECMO machine consists of different components such as pumps, controllers, oxygenators, cannula and accessories.
Due to the expansive use of veno-arterial ECMO machines in case of cardiac collapse, veno-arterial modal segment of ECMO machine market is expected to hold a major market share while increasing cases of cardiac shock is expected to help in the fast growth of veno-venous modal segment in the coming years.ECMO machine market has several application segmentations which include respiratory, cardiac and extracorporeal cardiopulmonary resuscitation.
Global nerve repair and regeneration market size Research Report: by Product, (Neurostimulation & Neuromodulation Devices and Biomaterials), by Application, (Neurostimulation and Neuromodulation Surgeries, Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Stem Cell Therapy and others), by End User (Hospitals & Clinics, Ambulatory Surgery Centers and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2024Global Global nerve repair and regeneration market size Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making.
This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability.
It provides information on trends and developments, and focuses on Markets and materials, capacities and technologies, and on the changing structure of the Serotonin Supplements Market.Some of the key players operating for the global market analysis are Boston Scientific Corporation, LivaNova PLC, Axogen Corporation, Integra LifeSciences, Abbott, Stryker Corporation, Nuvectra Corporation, NeuroPace, Polyganics, and Medtronic.The report presents an all-inclusive database in a systematic and highly comprehensive manner.
It intends to offer valid, factual, reliable, and easily understandable information about the which makes it more eloquent.
Our analysis team applies a tried and tested primary and secondary research methodology to provide accurate and indubitable findings.Market Segmentation:Global nerve repair and regeneration market size, by ProductNeurostimulation and Neuromodulation Devices Internal Neurostimulation DevicesSpinal Cord StimulationDeep Brain StimulationVagus Nerve StimulationSacral Nerve StimulationGastric Electrical StimulationExternal Neurostimulation DevicesTranscutaneous Electrical Nerve StimulationTranscranial Magnetic StimulationBiomaterialsNerve ConduitsNerve ProtectorsNerve Wraps Nerve ConnectorsGlobal nerve repair and regeneration market size, by ApplicationNeurostimulation and Neuromodulation SurgeriesInternal Neurostimulation and Neuromodulation SurgeriesExternal Neurostimulation and Neuromodulation SurgeriesDirect Nerve Repair/NeurorrhaphyNerve GraftingAutograftsAllograftsXenograftsStem Cell TherapyOthersAccess Complete Detailed TOC Research Report at https://www.marketresearchfuture.com/reports/nerve-regeneration-market-1202This report focuses on the Global nerve repair and regeneration market size status, future forecast, growth opportunity, key market and key players.
The study objectives are to present the Global nerve repair and regeneration market size development in United States, Europe and China.
Vagal Nerve Stimulation (VNS) Market Information: By Product (Implantable VNS Devices and External VNS Devices), By Application (Depression, Epilepsy, Migraine, And Others), By End Users (Hospitals, Ambulatory Surgical Centers, And Others) - Global Forecast Till 2027Market HighlightsVagus nerve stimulation is a treatment for neurological disorders like epilepsy that involves a stimulator or pulse generator, which is placed inside the body and connected to the left vagus nerve in the neck.
The stimulator sends regular, mild electrical stimulations through this nerve to help calm down the irregular electrical brain activity that leads to seizures.
The treatment for epilepsy works differently from patient to patient and vagus nerve stimulation therapy is a form of treatment for people with epilepsy whose seizures are not controlled with medication.
Implants like electronic neck implant are important for treating neurological disorder such as epilepsy.
The increasing focus of various government agencies on treating epilepsy, depression, and heart attacks will have a positive impact on the growth of the market.
Rapidly developing economy, increasing healthcare expenditure, and government initiatives for research & development will drive the market in China and India over the assessment period.The Middle East & Africa holds the least share of the global market due to limited availability of medical facilities.
Cardiac Implants Market OverviewCardiac implants are specifically designed to monitor irregular heartbeats in people with heart rhythm disorders.
Such disorders are mainly caused by problems associated with the heart’s electrical system, which signals the heart to pump blood throughout the body.
The global cardiac implants market, as per a report by Market Research Future (MRFR) is touted to register a CAGR of 7.82%, surpassing a valuation of USD 38,054.3 million during the forecast period (2019-2023).Cardiac implants are extensively used to treat myocardial ischemia, acute myocardial infarction, and arrhythmias.
Healthcare organizations and hospitals indicate cardiovascular implants at risk of cardiac disorders to offer artificial control in patient’s heartbeat.
The rising focus on R is considered a key trend impacting the market positively.
Such developments will drive the market growth in the years to come.On the contrary, infections related to implantable pacemakers in cardiac patients will remain a major restraining factor to the market growth across the globe.Cardiac Implants Market Regional FrontiersGeographically, the cardiac implants market spans across America, Europe, Asia Pacific, and the Middle East & Africa.Considering the global scenario, America is predicted to command the largest market share, mainly due to the soaring incidences of cardiac diseases, coupled with the increased adoption rate of cardiac implantable electronic devices in the region.
Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others.
As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period.The structural heart devices market is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes.
In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed.
A number of clinical trials and technology developments are underway, which is likely to provide the structural heart devices market opportunities for growth in the coming years.Structural Heart Devices Market SegmentationThe structural heart devices market has been segmented based on type, indication, procedure, and end-user.By type, the structural heart devices market has been segmented into heart valve devices, occluders and delivery systems, annuloplasty rings, accessories, and other devices.
The repair procedures segment has been further segmented into closure procedures, annuloplasty, valvuloplasty, and TMVR procedures.By end-user, the structural heart devices market has been segmented into hospitals, ambulatory surgery centers, and others.
High prevalence of cardiovascular disorders, fast uptake of the latest technologies, and high healthcare expenditure are the factors that are driving the North America market.
